MBIA, Inc. (NYSE:MBI)‘s stock had its “buy” rating reaffirmed by equities researchers at MKM Partners in a note issued to investors on Thursday.

A number of other research firms have also recently issued reports on MBI. BidaskClub cut MBIA from a “hold” rating to a “sell” rating in a research report on Saturday, August 5th. BTIG Research restated a “buy” rating and set a $14.00 price objective on shares of MBIA in a research report on Wednesday, September 6th.

Shares of MBIA (NYSE MBI) traded down 3.02% during trading on Thursday, reaching $7.71. The company had a trading volume of 7,639,404 shares. The stock has a 50 day moving average price of $9.83 and a 200 day moving average price of $9.18. The firm’s market capitalization is $970.04 million. MBIA has a 12 month low of $7.14 and a 12 month high of $11.65.

MBIA (NYSE:MBI) last released its quarterly earnings data on Tuesday, August 8th. The insurance provider reported ($1.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.01 by ($1.10). The firm had revenue of $72.00 million during the quarter, compared to analyst estimates of $87.85 million. The company’s revenue for the quarter was down 39.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.12 EPS. On average, equities research analysts forecast that MBIA will post ($0.76) EPS for the current year.

MBIA announced that its Board of Directors has approved a stock buyback plan on Tuesday, June 27th that authorizes the company to repurchase $250.00 million in outstanding shares. This repurchase authorization authorizes the insurance provider to reacquire up to 21.7% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s board of directors believes its shares are undervalued.

COPYRIGHT VIOLATION NOTICE: This story was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another site, it was copied illegally and reposted in violation of U.S. and international copyright & trademark law. The original version of this story can be viewed at https://www.thecerbatgem.com/2017/10/05/mkm-partners-reaffirms-buy-rating-for-mbia-inc-mbi.html.

A number of hedge funds have recently made changes to their positions in MBI. First Trust Advisors LP boosted its stake in MBIA by 104.9% in the 1st quarter. First Trust Advisors LP now owns 229,277 shares of the insurance provider’s stock valued at $1,942,000 after buying an additional 117,365 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in MBIA by 11.6% in the 1st quarter. Bank of New York Mellon Corp now owns 743,501 shares of the insurance provider’s stock valued at $6,297,000 after buying an additional 77,366 shares in the last quarter. UBS Asset Management Americas Inc. boosted its stake in MBIA by 20.4% in the 1st quarter. UBS Asset Management Americas Inc. now owns 105,775 shares of the insurance provider’s stock valued at $896,000 after buying an additional 17,886 shares in the last quarter. Karp Capital Management Corp acquired a new stake in MBIA in the 1st quarter valued at $189,000. Finally, Parametric Portfolio Associates LLC boosted its stake in MBIA by 24.3% in the 1st quarter. Parametric Portfolio Associates LLC now owns 714,510 shares of the insurance provider’s stock valued at $6,052,000 after buying an additional 139,455 shares in the last quarter. 92.03% of the stock is currently owned by institutional investors and hedge funds.

About MBIA

MBIA Inc is a holding company. The Company, through its subsidiaries, is engaged in the financial guarantee insurance businesses in the industry. The Company manages its business within three segments: United States (U.S.) public finance insurance; corporate, and international and structured finance insurance.

Receive News & Stock Ratings for MBIA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MBIA Inc. and related stocks with our FREE daily email newsletter.